Similar articles

• [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].

  Ligorria C, Montaña E, Virgili N. Ligorria C, et al. Med Clin (Barc). 1989 Nov 25;93(17):676. Med Clin (Barc). 1989. PMID: 2559266 Spanish. No abstract available.
• Somatostatin analogs in the management of gastrointestinal tumors.

  Lamberts SW. Lamberts SW. Horm Res. 1988;29(2-3):118-20. doi: 10.1159/000180985. Horm Res. 1988. PMID: 2900191
• Somatostatin analogues in the management of benign insulinomas.

  Laron Z. Laron Z. Isr J Med Sci. 1990 Jan;26(1):1-2. Isr J Med Sci. 1990. PMID: 2155883 Review. No abstract available.
• [Preoperative treatment of hypoglycemia caused by an insulinoma with the somatostatin analog SMS 201-995].

  Sánchez García Cervigón P, Fernández Navarro JI, Salmerón de Diego J, Caballero Asensi A, Cornelio Hernández F, Jara Albarrán A. Sánchez García Cervigón P, et al. Med Clin (Barc). 1987 Oct 17;89(12):511-3. Med Clin (Barc). 1987. PMID: 2890800 Spanish. No abstract available.
• Octreotide: Jack-of-all-trades or expensive orphan?

  Offerhaus L. Offerhaus L. Neth J Med. 1988 Jun;32(5-6):265-9. Neth J Med. 1988. PMID: 2899297 Review. No abstract available.